Suzanne Cory
Melbourne, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Trisomy 8 Defines a Distinct Subtype of Myeloproliferative Neoplasms Driven by the MYC-Alarmin Axis.
Trisomy 8 Defines a Distinct Subtype of Myeloproliferative Neoplasms Driven by the MYC-Alarmin Axis.
Journal: Blood cancer discovery
Published: October 09, 2023
MNT suppresses T cell apoptosis via BIM and is critical for T lymphomagenesis.
Journal: Cell death and differentiation
Published: February 08, 2022
CITED2 coordinates key hematopoietic regulatory pathways to maintain the HSC pool in both steady-state hematopoiesis and transplantation.
Journal: Stem cell reports
Published: June 02, 2021
Phosphatidylserine hide-and-seek.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: November 18, 2018
Differential effects of Vav-promoter-driven overexpression of BCLX and BFL1 on lymphocyte survival and B cell lymphomagenesis.
Journal: The FEBS journal
Published: December 13, 2017
Impact of elevated anti-apoptotic MCL-1 and BCL-2 on the development and treatment of MLL-AF9 AML in mice.
Journal: Cell death and differentiation
Published: November 06, 2017
Anti-apoptotic A1 is not essential for lymphoma development in Eµ-Myc mice but helps sustain transplanted Eµ-Myc tumour cells.
Journal: Cell death and differentiation
Published: September 15, 2017
The BCL-2 arbiters of apoptosis and their growing role as cancer targets.
Journal: Cell death and differentiation
Published: June 08, 2017
Mnt modulates Myc-driven lymphomagenesis.
Journal: Cell death and differentiation
Published: June 02, 2017
Anti-apoptotic proteins BCL-2, MCL-1 and A1 summate collectively to maintain survival of immune cell populations both in vitro and in vivo.
Journal: Cell death and differentiation
Published: November 17, 2016
Last Updated: 09/26/2026